Literature DB >> 4879400

Interaction of rifamycin with bacterial RNA polymerase.

W Wehrli, F Knüsel, K Schmid, M Staehelin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 4879400      PMCID： PMC225211          DOI： 10.1073/pnas.61.2.667

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  14 in total

1.  Inhibition of initiation of DNA-dependent RNA synthesis by an antibiotic B44p.

Authors:  S Mizuno; H Yamazaki; K Nitta; H Umezawa
Journal:  Biochem Biophys Res Commun       Date:  1968-02-26       Impact factor: 3.575

2.  The specific inhibition of the DNA-directed RNA synthesis by rifamycin.

Authors:  G Hartmann; K O Honikel; F Knüsel; J Nüesch
Journal:  Biochim Biophys Acta       Date:  1967

3.  Molecular weight of the 13-S subunit of DNA-dependent RNA polymerase from Escherichia coli.

Authors:  H Priess; W Zillig
Journal:  Biochim Biophys Acta       Date:  1967-08-15

4.  Influence of salts on RNA synthesis by DNA-dependent RNA-polymerase from Escherichia coli.

Authors:  R L Millette; W Zillig; G Walter
Journal:  Eur J Biochem       Date:  1967-12

5.  Initiation by the DNA-dependent RNA polymerase.

Authors:  D D Anthony; E Zeszotek; D A Goldthwait
Journal:  Proc Natl Acad Sci U S A       Date:  1966-09       Impact factor: 11.205

Review 6.  Rifamycin SV. A review.

Authors:  N Bergamini; G Fowst
Journal:  Arzneimittelforschung       Date:  1965-08

7.  Some physical properties of RNA polymerase.

Authors:  J P Richardson
Journal:  Proc Natl Acad Sci U S A       Date:  1966-06       Impact factor: 11.205

8.  Rifampicin: a new orally active rifamycin.

Authors:  N Maggi; C R Pasqualucci; R Ballotta; P Sensi
Journal:  Chemotherapy       Date:  1966       Impact factor: 2.544

9.  Studies on the binding of RNA polymerase to polynucleotides.

Authors:  O W Jones; P Berg
Journal:  J Mol Biol       Date:  1966-12-28       Impact factor: 5.469

10.  Pharmacokinetic and metabolic studies with labeled rifamycin antibiotics.

Authors:  H Keberle; H Meyer-Brunot; K Schmid
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1966
View more
  95 in total

Review 1.  Suppression of Emergence of Resistance in Pathogenic Bacteria: Keeping Our Powder Dry, Part 1.

Authors:  G L Drusano; Arnold Louie; Alasdair MacGowan; William Hope
Journal:  Antimicrob Agents Chemother       Date:  2015-12-28       Impact factor: 5.191

Review 2.  Treatment of pulmonary disease caused by opportunist mycobacteria.

Authors:  J Banks
Journal:  Thorax       Date:  1989-06       Impact factor: 9.139

3.  RNA dependent RNA polymerase activity associated with the double-stranded RNA virus of Giardia lamblia.

Authors:  T C White; C C Wang
Journal:  Nucleic Acids Res       Date:  1990-02-11       Impact factor: 16.971

Review 4.  New antituberculous drugs derived from natural products: current perspectives and issues in antituberculous drug development.

Authors:  Masayuki Igarashi; Yoshimasa Ishizaki; Yoshiaki Takahashi
Journal:  J Antibiot (Tokyo)       Date:  2017-11-01       Impact factor: 2.649

5.  RifZ (AMED_0655) Is a Pathway-Specific Regulator for Rifamycin Biosynthesis in Amycolatopsis mediterranei.

Authors:  Chen Li; Xinqiang Liu; Chao Lei; Han Yan; Zhihui Shao; Ying Wang; Guoping Zhao; Jin Wang; Xiaoming Ding
Journal:  Appl Environ Microbiol       Date:  2017-03-31       Impact factor: 4.792

6.  The spectrum of spontaneous rifampin resistance mutations in the rpoB gene of Bacillus subtilis 168 spores differs from that of vegetative cells and resembles that of Mycobacterium tuberculosis.

Authors:  Wayne L Nicholson; Heather Maughan
Journal:  J Bacteriol       Date:  2002-09       Impact factor: 3.490

7.  NOVEL Escherichia coli dnaB mutant: direct involvement of the dnaB252 gene product in the synthesis of an origin-ribonucleic acid species during initiaion of a round of deoxyribonucleic acid replication.

Authors:  J W Zyskind; D W Smith
Journal:  J Bacteriol       Date:  1977-03       Impact factor: 3.490

8.  Metabiolic products of microorganisms. Tirandamycin B(author's transl).

Authors:  H Hagenmaier; K H Jaschke; L Santo; M Scheer; H Zähner
Journal:  Arch Microbiol       Date:  1976-08       Impact factor: 2.552

9.  Effect of rifamycins and related antibiotics on the deoxyribonucleic acid-dependent ribonucleic acid polymerase of vaccinia virus particles.

Authors:  J F Szilágyi; T H Pennington
Journal:  J Virol       Date:  1971-08       Impact factor: 5.103

10.  Rifampin disrupts conjugal and chromosomal deoxyribonucleic acid metabolism in Escherichia coli K-12 carrying some IncIalpha plasmids.

Authors:  G J Boulnois; M J Beddoes; B M Wilkins
Journal:  J Bacteriol       Date:  1979-05       Impact factor: 3.490
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.